People with diabetes rely on self-monitoring blood glucose systems (SMBG) to monitor their blood glucose levels and make important decisions about how to treat their diabetes, including how much insulin is required to restore glucose levels to a normal range. Typically, a person with diabetes tests his or her blood sugar before eating or exercising to find out if they’re within a normal range. The patient then uses insulin or diet modifications to bring his/her blood glucose to a healthy level. The goal is to maintain regular glucose levels (between 70 and 180 mg/dl depending on meal timing), and reduce the chances of a severe drop in blood glucose levels, triggering a potentially life-threatening hypoglycemic event.1
If a SMBG system is inaccurate and provides a false reading, it puts a patient at risk of dosing too much or too little insulin. If this occurs and too much insulin is given, it can bring blood glucose levels down to dangerously low levels, putting the patient at risk of severe hypoglycemia and possible hospitalization. It is therefore critical that SMBG systems are accurate and provide patients and caregivers with the right information to make informed treatment decisions.
The U.S. spends approximately $245 billion annually on diabetes care with $176 billion in direct medical costs, and $69 billion in indirect costs due to disability, work loss and premature mortality.4